Diabetes mellitus in elderly patients. Is it different?

The American Journal of Medicine

Volumn 83, Issue 3, 1987, Pages 533-544

  Morley, John E ^a,b   Mooradian, Arshag D ^a,b   Rosenthal, Mark J ^a,b   Kaiser, Fran E ^a,b  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMPLICATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EXTERNAL AUDITORY CANAL; FACIAL NERVE PARALYSIS; HUMAN; INFECTION; PSEUDOMONAS AERUGINOSA; REVIEW;

AGED; AGING; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FOOT DISEASES; GLUCOSE; HUMAN; HYPERGLYCEMIA; NUTRITIONAL STATUS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0023614735     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90767-4     Document Type: Review

References (137)

1. Diabetes mellitus in the elderly
2. Diabetes in the elderly: diagnosis and epidemiology
3. Prevalence of elderly patients in a hospital diabetic population
4. Diabetes in the aged: under-diagnosis and over treatment
5. Impact of policy and procedure changes on hospital days among diabetic nursing home residents
6. Diabetes in the elderly—a neglected area?
7. The effect of aging on carbohydrate metabolism: a comprehensive review and a practical approach to a clinical problem
8. Some observations on sugar tolerance, with special reference to variations found at different ages
9. The physiological significance of the glucose intolerance of aging
10. 1c
11. Glucose as a mediator of aging
12. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics
13. The effect of age on insulin-degrading activity in rat islet tissue
14. Influence of age on clearance of insulin in man
15. Age, glucose intolerance and non-insulin-dependent diabetes mellitus
16. Effect of habitual physical activity on regulation of insulin-stimulated glucose disposal in older males
17. Characterization of the insulin resistance of aging
18. Mechanisms of insulin resistance in aging
19. Influence of aging on insulin receptor binding and metabolic effects of insulin on human adipose tissue
20. Insulin resistance in the aged: the role of peripheral insulin receptors
21. The effects of aging on glucose metabolism in adipocytes from Fischer rats
22. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased B-cell function
23. Prognosis of diabetes mellitus in a geographically defined population
24. Diabetes
25. Age-related changes in plasma growth hormone response to growth hormone releasing factor in man
26. Secretion of corticotrophin and somatotrophin by the senescent adenohypophysis in man
27. Effects of aging on catcholamine metabolism
28. Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase
29. Studies on the pathogenesis of the diabetic patients
30. The dawn phenomenon does not occur in normal elderly subjects
31. The “dawn” phenomenon—a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus
32. Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion
33. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus
34. Failure to detect the “dawn phenomenon” in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion
35. Absence of the dawn phenomenon in healthy elderly male subjects
36. Growth hormone response to insulin hypoglycemia in the elderly
37. Human GH and cortisol response to insulin stimulation in the aged
38. Counterregulatory responses to insulin-induced glucose reduction in the elderly
39. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy
40. Cognitive function during hypoglycemia in type 1 diabetes mellitus
41. Uncontrolled diabetes mellitus in adults: experience in treatment of diabetic ketoacidosis and hyperosmolar nonketotic coma with low-dose insulin and uniform treatment regimen
42. Coma in the nonketotic diabetic
43. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy
44. Retinopathy in older type II diabetics: association with glucose control
45. Urinary glucose testing inaccuracies among diabetic patients: effect of acquired color vision deficiency caused by diabetic retinopathy
46. Analysis of individual cataract patients and their lenses: a progress report
47. The epidemiology of senile cataracts: a review
48. Polyol pathway metabolites in human cataracts
49. Intraocular pressure, cardiovascular risk variables and visual field defects
50. The epidemiology of open-angle glaucoma: a review
51. Ophthalmic timolol causing altered hypoglycemic response in a diabetic
52. The aging eye
53. Temporal arteritis
54. Ophthalmoplegia in diabetes mellitus
55. Diagnosis of diabetic eye disease
56. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1948 and 1973
57. Pathogenesis of diabetic neuropathy
58. Diabetic neuropathy
59. Polyglandular autoimmune syndromes
60. Neuropathy in the diabetic and non-diabetic populations
61. Neuroendocrine effects of endogenous opioid peptides in human subjects: a review
62. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine
63. Opioid modulation of appetite
64. Why is diabetic neuropathy painful?
65. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy
66. Diabetic amyotrophy
67. Diabetic neuropathie cachexia
68. Diabetic throacoabdominal neuropathy: a cause for chest and abdominal pain
69. Morbidity and mortality in diabetics in the Framingham population
70. Controllable risk factors for stroke: preventive implications of trends in stroke mortality
71. A postmortem study of vascular disease in diabetics
72. Intracranial vascular disease in diabetes mellitus
73. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus
74. Nervous system effects of cardiac arrest in monkeys
75. Moderate hyperglycemia augments ischemic brain damage: a neuropathological study in the rat
76. Clinical restitution following cerebral ischemia in hypo-, normo- and hyperglycemic rats
77. Decreased cognitive function in aging non-insulin dependent diabetic patients
78. Epidemiology of dysphoria and depression in an elderly population
79. Effective low-dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients: a double-blind study
80. Impotence
81. Multidisiplinary survey of erectile impotence
82. Impotence in medical clinic outpatients
83. The mechanism for impotence in diabetes mellitus
84. The mechanism for impotence in diabetes mellitus
85. Vascular factor in erectile failure among diabetics
86. Hyperprolactinemia in male diabetics
87. A psychoendocrinological study of erectile psychogenic impotence: a comparison between normal patients and patients with abnormal reaction in glucose tolerance test
88. Previously unrecognized diabetes mellitus in sexually impotent men
89. The menace of diabetic gangrene
90. The effect of age on creatinine clearance in man
91. Reduced thirst after water deprivation in healthy elderly men
92. Renal medullary necrosis (editorial)
93. Hyporeninemic hypoaldosteronism
94. Diabetic complications in lens and nerve and their prevention by sulindac and sorbinil—two novel aldase reductase inhibitors
95. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy
96. Malignant external otitis: further considerations
97. Malignant external otitis a severe form of otitis in diabetic patients
98. Host defense and infections in diabetes mellitus
99. Tuberculosis among elderly persons
100. The reactivation of tuberculosis in New York City in 1967
101. Glucose intolerance in pulmonary tuberculosis
102. Ageing, immune response and mortality
103. Reliability of skin testing in the oldest old
104. Recommendations for prevention and control of influenza
105. Pneumococcal Vaccine
106. Revaccination of renal transplant and hemodialysis recipients and pneumococcal vaccine
107. Hypothermia in hypoglycemia
108. Acute pancreatitis and diabetic ketoacidoses in accidental hypothermia and hypothermic myxedema
109. Hypothermia: a complication of diabetic ketoacidosis
110. Hypothermia: the Bellevue experience
111. Risk of hypothermia in elderly patients with diabetes
112. Nutritional status of the elderly
113. Abnormal zinc metabolism in type II diabetes mellitus
114. The role of zinc supplementation in type II diabetes mellitus
115. Serum-zinc and healing of venous leg ulcers
116. Micronutrient status in diabetes mellitus
117. Chromium and nicotinic acid in normalizing glucose tolerance
118. Routine serum magnesium analysis
119. Diabetic osteopenia and circulating levels of vitamin D metabolites in type II (noninsulin-dependent) diabetes
120. Diabetes in the elderly: diagnosis, pathogenesis and therapy
121. Effect of obesity on total mortality
122. UCLA grand rounds: nutrition and the elderly
123. Diet and the diabetic patients
124. Glycemic index of foods a physiological basis for carbohydrate exchange
125. Chlorpropamide hyponatremia—drug-induced inappropriate antiduretic hormone activity
126. Chlorpropamide-induced hyponatremia: incidence and risk factors
127. Review of glyburide after one year on the market
128. Glibenclamide-associated hypoglycemia: a report of 57 cases
129. Once daily use of glyburide
130. Diumal pattern of plasma insulin and blood glucose during gliberclamide and glipizide therapy in elderly diabetics
131. Do diabetic patients inject accurate doses of insulin?
132. Accuracy of insulin injection in elderly patients
133. Evaluation of glycosylated hemoglobin in diabetic patients